Clinical trials
Relatives clinical trials
Below are recruiting relatives clinical trials, each written for real people, not researchers. We’re tracking 2,011 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07644715Recruiting
AI Analysis of Heart Rhythms and Immune-Related Heart Damage
This study uses artificial intelligence to analyze heart electrical recordings (ECGs) from existing patient databases to better detect dangerous heart rhythm problems and heart inflammation caused by cancer immunotherapy. Researchers are not giving any new treatments—they're studying existing data to improve diagnosis.
ParisAges Any age - NCT07644897RecruitingPhase 2
Thymosin Alpha 1 Plus Anti-PD-1 for Advanced Melanoma in Older Adults
This trial tests a combination of two drugs—thymosin alpha 1 (an immune-boosting protein) and an anti-PD-1 antibody (a cancer immunotherapy)—in patients 60 and older with advanced melanoma that cannot be surgically removed. The goal is to help the immune system fight the cancer more effectively.
Guangzhou, GuangdongAges 60 years+ - NCT07646782Recruiting
Human Observatory Study: Aging and Longevity Research
This study observes how people age over time to better understand what helps people live longer and healthier lives. You'll share health information through surveys or online screening, and researchers will track changes in your health and wellbeing.
Boulder, ColoradoAges 18 years+ - NCT07650968RecruitingPhase 4
Prostate Medication Adjustment After Sudden Inability to Urinate
This trial tests whether increasing your prostate medication (tamsulosin) or switching to a different medication (silodosin) helps you urinate normally again after a sudden blockage caused by an enlarged prostate. The goal is to help you avoid long-term catheter use.
Banī Suwayf, Beni Suweif GovernorateAges 50 years+ - NCT07653295Recruiting
Study of Tıpmed revision hip replacement safety
This study follows patients who already had a revision hip replacement using the Tıpmed system. Researchers want to confirm the implant is safe and works well over time.
BalıkesirAges 18 years+ - NCT07653269Recruiting
Tracking eye changes to predict AMD progression
This study uses eye imaging and other tests to predict if early age-related macular degeneration (AMD) will progress to a more advanced stage. It aims to help doctors identify who might need closer monitoring in the future.
SingaporeAges 55 years+ - NCT07656324Recruiting
Fatigue study for cancer patients in China
This study looks at fatigue in Chinese cancer patients to understand how common it is and how it affects their health. You may join if you have a confirmed cancer diagnosis and are at least 18 years old.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07664462Recruiting
Heat and Altitude: Male Exercise Study
This study tests how your body handles working in heat when you are also at a simulated high altitude. The results could help understand physical limits and safety in jobs or sports.
Ottawa, OntarioAges 18–70 - NCT07666022RecruitingPhase 1
Safety study of MF1 for Parkinson's-related constipation
This early-phase study tests a new treatment called MF1 for Parkinson's-related symptoms, especially constipation. It first checks safety in healthy volunteers, then in people with Parkinson's who have slow bowel movements.
Sumida-ku, TokyoAges 18–85 - NCT07668804RecruitingPhase 1/Phase 2
Study of an eye implant for geographic atrophy from dry AMD
This trial is testing a new eye implant (TO-O-1007) to see if it's safe and helps slow vision loss from geographic atrophy, a late stage of dry age-related macular degeneration (AMD). The implant is placed inside the eye and releases medicine over time.
Hurstville, New South Wales (nsw)Ages 50 years+ - NCT07669168Recruiting
Health study comparing usual care vs. extra support
This study looks at whether adding extra health support helps people stay healthier over time. You would be followed for a while and asked to share how you are doing.
Boulder, ColoradoAges 18 years+ - NCT07669467RecruitingPhase 3
Nuvastatic for fatigue in triple-negative breast cancer patients
This trial tests whether Nuvastatic, a natural supplement, can help reduce fatigue in women with triple-negative breast cancer who are about to start chemotherapy. If you have stable or worsening fatigue and meet the other criteria, you may be able to join.
Visakhapatnam, Andhra PradeshAges 18–65 - NCT07669454RecruitingPhase 3
Nuvastatic® for metastatic colorectal cancer
This trial tests a new capsule (Nuvastatic®) added to standard chemotherapy for people with metastatic colorectal cancer. The goal is to see if it helps shrink tumors and improve well-being.
Visakhapatnam, Andhra PradeshAges 18–65 - NCT07669519RecruitingPhase 3
Supplement for fatigue in stage IV colon cancer
This study tests an oral supplement (Nuvastatic) to see if it helps reduce fatigue in people with stage IV colon cancer who are starting chemotherapy for the first time. If you are 18–65 and have fatigue that is affecting you, this trial might offer a way to feel better.
Srikakulam, Andhra PradeshAges 18–65 - NCT07670221Recruiting
Nurse-led program for taste changes in breast cancer patients
This trial tests a nurse-guided self-management program for women with breast cancer who experience taste changes from taxane chemotherapy. The program aims to help you manage taste alterations and improve your quality of life during treatment.
IzmirAges 18 years+ - NCT07672119Recruiting
Heart risks in older men on enzalutamide or darolutamide
This study looks at heart-related risks in older men with advanced prostate cancer who are taking enzalutamide or darolutamide. It may help doctors better understand how to manage heart health during treatment.
Whippany, New JerseyAges 55 years+ - NCT07672275Recruiting
How blood transfusions affect stress markers in newborns
This study looks at how blood transfusions change stress-related substances in the blood of newborns. It might help doctors understand how transfusions affect babies in the NICU.
Graz, StyriaAges 5 minutes–5 months - NCT07642401Enrolling by invitation
Building models to understand esophageal cancer
This research study uses medical records and imaging from patients with various esophageal conditions—from inflammation to cancer—to develop better diagnostic and prediction tools. Researchers want to understand what changes in the esophagus lead to cancer and how to catch it earlier.
Anyang, HenanAges 18–90 - NCT07636876Enrolling by invitation
Italian MS and Related Disorders Patient Registry
This is a registry study that collects health information from people with multiple sclerosis and related conditions. By joining, you help researchers better understand these diseases and improve future treatments.
Genova, GenovaAges Any age - NCT07600892Enrolling by invitation
Pain-at-Work Toolkit for managing chronic pain at work
This study tests a toolkit designed to help working adults manage chronic pain while on the job. The toolkit aims to make work more manageable and enjoyable for people living with ongoing pain.
Nottingham, NottinghamshireAges 18 years+ - NCT07549295Enrolling by invitationPhase 1
Melatonin to help babies grow better in the womb
This study tests whether melatonin (a natural sleep hormone) can help babies who are not growing well in the womb due to placental blood-flow problems. Researchers will measure if melatonin improves the baby's growth and health before delivery.
Shanghai, Shanghai MunicipalityAges 20–43 - NCT07541131Enrolling by invitation
Reducing HIV stigma to improve treatment access for drug users
This study tests whether reducing stigma and discrimination against people who use drugs can help more people access HIV treatment and prevention. You would participate in peer-led group sessions and surveys over 18 months to help researchers understand how stigma affects treatment access in Bishkek.
BishkekAges 18 years+ - NCT07515430Enrolling by invitation
Gut Bacteria and Cancer Symptoms in Children With Leukemia
This study looks at how the bacteria living in your child's gut may affect cancer-related symptoms (like nausea, fatigue, or pain) during leukemia treatment. Researchers will collect stool samples and track symptoms to understand this connection better.
Guangzhou, GuangdongAges 5–18 - NCT07511660Enrolling by invitation
Ovarian cell injection for perimenopause symptom relief
This trial tests injecting special cells called Muse cells into the ovaries to help relieve perimenopause symptoms and possibly restore ovarian function. It may help women experiencing irregular periods, hot flashes, sleep problems, mood changes, or trouble thinking clearly.
Monterrey, Nuevo LeónAges 28–70
Hear when a new Relatives trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for relatives?
- Yes. Clin2 currently lists 2,011 recruiting relatives studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a relatives trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a relatives trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.